RARRES2 and coronary artery disorder: According to the results of our ROC analysis for chemerin, the sensitivity and specificity for identifying CCTA-confirmed CAD at a cut-off value of 90.46 ng/mL were found to be 61% and 62%, respectively (Figure 3).